News Briefs Archive

Next-Generation Macular Pigment Optical Density Measurement Device Launches

June 7, 2023The ZX Pro, a device that allows eyecare professionals to measure macular pigment optical density.

EyePromise, an eye health nutraceutical company, has released the Zx Pro, which it says offers the latest in biomarker technology, allowing eyecare professionals to measure macular pigment optical density in a larger patient base. This portable device is equipped with an audio tutorial, making the need for staff-run exams discretionary and ensuring each test is completed accurately.

Using clinically proven technology called heterochromatic flicker photometry, the Zx Pro’s two-minute ocular test provides a score that directly correlates to the amount of dietary zeaxanthin and lutein in the eyes. This gives doctors a quantified measure to associate with patients’ level of risk. Low macular pigment optical density (MPOD) scores are a risk factor for several eye and overall health concerns, including blue light damage, poor contrast, difficulty seeing at night, light sensitivity, cognitive concerns, and age-related eye health issues.

“The idea for the Zx Pro grew from an understanding that MPOD is an invaluable biomarker combined with a need for a device that’s portable, creating flexibility for both research and practice,” said Pinakin Davey, PhD, OD, FAAO, a tenured professor at Western University of Health Sciences, College of Optometry and one of the clinical experts behind the research that developed the Zx Pro. “We also wanted to include features, such as the audio tutorial, to reduce staff requirements and variability of the exam explanation from patient to patient. It’s the latest cutting-edge technology to improve early patient identification and intervention. A remarkable achievement for both clinical and practical use.”

Andreas Wolf, EyePromise President, echoed Dr. Davey’s excitement: “This is a game-changing device for our eyecare partners and their patients. Because MPOD measurement can be utilized as a biomarker for eye and overall health and the exam is so fast and easy, it opens the opportunity for a broader audience to be measured and benefit from ocular nutrition. This allows more patients to be helped sooner, creating an invaluable measurement for vision for life.”

The Zx Pro joins EyePromise’s comprehensive line of clinically proven nutraceuticals and the Auto Refill Program (ARP), the industry-leading patient compliance program. These are all part of the new Zea Performance System, the nutritional program that helps deliver vision for life through a turnkey solution for MPOD measurement, nutraceutical prescription, a compliance program and patient and practice support.

For more information, visit eyepromise.com/zea-performance-system

To Top
Subscribe Today for Free...
And join more than 35,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.